Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cabenuva
Pharma
GSK bolsters case for long-acting HIV PrEP drug Apretude
With GSK girding for competition from Gilead, the company has presented strong results from three real-world studies of HIV prevention drug Apretude.
Kevin Dunleavy
Oct 16, 2024 1:26pm
GSK to triple long-acting Apretude supply to boost global access
Oct 7, 2024 10:56am
WHO flags increasing resistance to GSK's Tivicay in 4 countries
Mar 6, 2024 2:02pm
GSK's long-acting HIV med beats daily pills in some patients
Feb 21, 2024 2:00am
GSK sees £7B in HIV sales by 2026, updates next-gen timelines
Sep 28, 2023 9:00am
GSK sees slow build of RSV vax sales, still boosts '23 guidance
Jul 26, 2023 11:09am
